Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2023 Filed May 15, 2023 22:52 UTC |
Zheng YongxiangDirector
|
Exercise / conversionCommon Stock | 858 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-014700 · rdgdoc.xml · nonDerivative · entry 1 Zheng Yongxiang · CIK 0001910375 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On November 15, 2022, NovaBay Pharmaceuticals, Inc. effected a 1-for-35 reverse stock split of its common stock, which is reflected in the number of shares. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. F1 · balance_after: On November 15, 2022, NovaBay Pharmaceuticals, Inc. effected a 1-for-35 reverse stock split of its common stock, which is reflected in the number of shares. Read SEC document |
| December 06, 2022 Filed Dec 7, 2022 21:55 UTC |
Kunin AudreyChief Product Officer
|
SaleCommon Stock | 1 | $1.81 | $1.81 |
DisclosureSEC source: 0001437749-22-028673 · rdgdoc.xml · nonDerivative · entry 1 Kunin Audrey · CIK 0001738781 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control. Read SEC document |
| December 06, 2022 Filed Dec 7, 2022 21:55 UTC |
Kunin JeffreyPresident, DERMAdoctor, LLC
|
SaleCommon Stock | 1 | $1.81 | $1.81 |
DisclosureSEC source: 0001437749-22-028672 · rdgdoc.xml · nonDerivative · entry 1 Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control. Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 21:16 UTC |
Kunin AudreyDirector · Chief Product Officer
|
SaleCommon Stock | 5,960 | $2.10 | $12,545.20 |
DisclosureSEC source: 0001437749-22-028031 · rdgdoc.xml · nonDerivative · entry 1 Kunin Audrey · CIK 0001738781 · Director · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On November 15, 2022, the common stock of NovaBay Pharmaceuticals, Inc. split 1-for-35, and is reflected accordingly in the number of shares sold. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control. Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 21:15 UTC |
Kunin JeffreyPresident, DERMAdoctor, LLC
|
SaleCommon Stock | 5,960 | $2.10 | $12,545.20 |
DisclosureSEC source: 0001437749-22-028029 · rdgdoc.xml · nonDerivative · entry 1 Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On November 15, 2022, the common stock of NovaBay Pharmaceuticals, Inc. split 1-for-35, and is reflected accordingly in the number of shares sold. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control. Read SEC document |
| November 21, 2022 Filed Dec 5, 2022 22:30 UTC Amendment |
Kunin AudreyChief Product Officer
|
SaleCommon Stock | 5,960 | $2.10 | $12,545.20 |
DisclosureSEC source: 0001437749-22-028439 · rdgdoc.xml · nonDerivative · entry 1 Kunin Audrey · CIK 0001738781 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 F1 · shares: On November 15, 2022, the common stock of NovaBay Pharmaceuticals, Inc. split 1-for-35, and is reflected accordingly in the number of shares sold. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: The original Form 4, filed on November 23, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported that the reporting person beneficially owned no shares following the reported transaction when in fact the reporting person beneficially owned one share following the reported transaction. F4 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control. Read SEC document |
| November 21, 2022 Filed Dec 5, 2022 22:30 UTC Amendment |
Kunin JeffreyPresident, DERMAdoctor, LLC
|
SaleCommon Stock | 5,960 | $2.10 | $12,545.20 |
DisclosureSEC source: 0001437749-22-028438 · rdgdoc.xml · nonDerivative · entry 1 Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1 F1 · shares: On November 15, 2022, the common stock of NovaBay Pharmaceuticals, Inc. split 1-for-35, and is reflected accordingly in the number of shares sold. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: The original Form 4, filed on November 23, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported that the reporting person beneficially owned no shares following the reported transaction when in fact the reporting person beneficially owned one share following the reported transaction. F4 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control. Read SEC document |
| September 14, 2022 Filed Sep 17, 2022 00:45 UTC |
Hall JustinDirector · CEO, GC and Director
|
PurchaseCommon Stock | 10,000 | $0.15 | $1,500.00 |
DisclosureSEC source: 0001437749-22-022651 · rdgdoc.xml · nonDerivative · entry 1 Hall Justin · CIK 0001663021 · Director · CEO, GC and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,172 Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 22:26 UTC |
Kunin JeffreyPresident, DERMAdoctor, LLC
|
SaleCommon Stock | 291,368 | $0.16 | $46,094.42 |
DisclosureSEC source: 0001437749-22-022648 · rdgdoc.xml · nonDerivative · entry 1 Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 208,632 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.1565 to $0.1605. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 22:24 UTC |
Kunin AudreyDirector · Chief Product Officer
|
SaleCommon Stock | 291,368 | $0.16 | $46,094.42 |
DisclosureSEC source: 0001437749-22-022646 · rdgdoc.xml · nonDerivative · entry 1 Kunin Audrey · CIK 0001738781 · Director · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 208,632 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.1565 to $0.1605. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control. Read SEC document |
| May 21, 2022 Filed May 24, 2022 23:30 UTC |
Freiman Paul E.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-013459 · rdgdoc.xml · derivative · entry 3 Freiman Paul E. · CIK 0001410074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. Read SEC document |
| May 21, 2022 Filed May 24, 2022 23:30 UTC |
Freiman Paul E.Director
|
Exercise / conversionCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-013459 · rdgdoc.xml · nonDerivative · entry 1 Freiman Paul E. · CIK 0001410074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. Read SEC document |
| May 21, 2022 Filed May 24, 2022 23:31 UTC |
Zheng YenyouDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-013460 · rdgdoc.xml · derivative · entry 2 Zheng Yenyou · CIK 0001330748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. Read SEC document |
| May 21, 2022 Filed May 24, 2022 23:31 UTC |
Zheng YenyouDirector
|
Exercise / conversionCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-013460 · rdgdoc.xml · nonDerivative · entry 1 Zheng Yenyou · CIK 0001330748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. Read SEC document |
| May 21, 2022 Filed May 24, 2022 23:33 UTC |
WU MIJIADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-013461 · rdgdoc.xml · derivative · entry 2 WU MIJIA · CIK 0001664299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. Read SEC document |
| May 21, 2022 Filed May 24, 2022 23:33 UTC |
WU MIJIADirector
|
Exercise / conversionCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-013461 · rdgdoc.xml · nonDerivative · entry 1 WU MIJIA · CIK 0001664299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. Read SEC document |
| May 21, 2022 Filed May 24, 2022 23:28 UTC |
Sit SwanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-013458 · rdgdoc.xml · derivative · entry 2 Sit Swan · CIK 0001801128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. Read SEC document |
| May 21, 2022 Filed May 24, 2022 23:28 UTC |
Sit SwanDirector
|
Exercise / conversionCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-013458 · rdgdoc.xml · nonDerivative · entry 1 Sit Swan · CIK 0001801128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. Read SEC document |
| May 11, 2022 Filed May 14, 2022 00:31 UTC |
Freiman Paul E.Director
|
GrantRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-012433 · rdgdoc.xml · derivative · entry 1 Freiman Paul E. · CIK 0001410074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. Read SEC document |
| May 11, 2022 Filed May 14, 2022 00:32 UTC |
Zheng YenyouDirector
|
GrantRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-012435 · rdgdoc.xml · derivative · entry 1 Zheng Yenyou · CIK 0001330748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. Read SEC document |
| May 11, 2022 Filed May 14, 2022 00:32 UTC |
Zheng YongxiangDirector
|
GrantRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-012436 · rdgdoc.xml · derivative · entry 1 Zheng Yongxiang · CIK 0001910375 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. Read SEC document |
| May 11, 2022 Filed May 14, 2022 00:33 UTC |
WU MIJIADirector
|
GrantRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-012438 · rdgdoc.xml · derivative · entry 1 WU MIJIA · CIK 0001664299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. Read SEC document |
| May 11, 2022 Filed May 14, 2022 00:33 UTC |
Sit SwanDirector
|
GrantRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-012437 · rdgdoc.xml · derivative · entry 1 Sit Swan · CIK 0001801128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. Read SEC document |
| May 11, 2022 Filed May 14, 2022 00:31 UTC |
Garlikov JulieDirector
|
GrantRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-012434 · rdgdoc.xml · derivative · entry 1 Garlikov Julie · CIK 0001793266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 01:03 UTC |
Hall JustinDirector · CEO, GC and Director
|
PurchaseCommon Stock | 69,767 | $0.43 | $29,999.81 |
DisclosureSEC source: 0001437749-21-027958 · rdgdoc.xml · nonDerivative · entry 1 Hall Justin · CIK 0001663021 · Director · CEO, GC and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,172 Read SEC document |
| December 06, 2021 Filed Dec 6, 2021 21:30 UTC | PurchaseCommon Stock | 36,765 | $0.44 | $16,176.60 |
DisclosureSEC source: 0001437749-21-027933 · rdgdoc.xml · nonDerivative · entry 2 Jones Andrew D. · CIK 0001811872 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,461 Read SEC document |
|
| December 03, 2021 Filed Dec 6, 2021 21:30 UTC | PurchaseCommon Stock | 8,690 | $0.44 | $3,823.60 |
DisclosureSEC source: 0001437749-21-027933 · rdgdoc.xml · nonDerivative · entry 1 Jones Andrew D. · CIK 0001811872 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,696 Read SEC document |
|
| December 03, 2021 Filed Dec 7, 2021 22:43 UTC |
Kunin AudreyChief Product Officer
|
PurchaseCommon Stock | 101,650 | $0.46 | $47,013.13 |
DisclosureSEC source: 0001437749-21-028027 · rdgdoc.xml · nonDerivative · entry 1 Kunin Audrey · CIK 0001738781 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 500,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.4600 to $0.4650. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 22:46 UTC |
Kunin JeffreyPresident, DERMAdoctor, LLC
|
PurchaseCommon Stock | 101,650 | $0.46 | $47,013.13 |
DisclosureSEC source: 0001437749-21-028029 · rdgdoc.xml · nonDerivative · entry 1 Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 500,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.4600 to $0.4650. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control. Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 21:31 UTC |
Kunin JeffreyPresident, DERMAdoctor, LLC
|
PurchaseCommon Stock | 262,369 | $0.48 | $124,887.64 |
DisclosureSEC source: 0001437749-21-027935 · rdgdoc.xml · nonDerivative · entry 1 Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 398,350 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.4650 to $0.4900. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control. Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 21:31 UTC |
Kunin AudreyChief Product Officer
|
PurchaseCommon Stock | 262,369 | $0.48 | $124,887.64 |
DisclosureSEC source: 0001437749-21-027934 · rdgdoc.xml · nonDerivative · entry 1 Kunin Audrey · CIK 0001738781 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 398,350 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.4650 to $0.4900. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:30 UTC |
Kunin AudreyChief Product Officer
|
PurchaseCommon Stock | 14,848 | $0.49 | $7,275.52 |
DisclosureSEC source: 0001437749-21-027852 · rdgdoc.xml · nonDerivative · entry 1 Kunin Audrey · CIK 0001738781 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 135,981 F1 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:30 UTC |
Kunin JeffreyPresident, DERMAdoctor, LLC
|
PurchaseCommon Stock | 14,848 | $0.49 | $7,275.52 |
DisclosureSEC source: 0001437749-21-027850 · rdgdoc.xml · nonDerivative · entry 1 Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 135,981 F1 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 21:30 UTC |
Kunin JeffreyPresident, DERMAdoctor, LLC
|
PurchaseCommon Stock | 30,000 | $0.46 | $13,800.00 |
DisclosureSEC source: 0001437749-21-027708 · rdgdoc.xml · nonDerivative · entry 1 Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 121,133 F1 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 21:30 UTC |
Kunin AudreyChief Product Officer
|
PurchaseCommon Stock | 30,000 | $0.46 | $13,800.00 |
DisclosureSEC source: 0001437749-21-027706 · rdgdoc.xml · nonDerivative · entry 1 Kunin Audrey · CIK 0001738781 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 121,133 F1 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 21:46 UTC |
Kunin AudreyChief Product Officer
|
PurchaseCommon Stock | 66,133 | $0.46 | $30,368.27 |
DisclosureSEC source: 0001437749-21-027397 · rdgdoc.xml · nonDerivative · entry 2 Kunin Audrey · CIK 0001738781 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 91,133 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.4545 to $0.4610. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 21:46 UTC |
Kunin JeffreyPresident, DERMAdoctor, LLC
|
PurchaseCommon Stock | 66,133 | $0.46 | $30,368.27 |
DisclosureSEC source: 0001437749-21-027396 · rdgdoc.xml · nonDerivative · entry 2 Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 91,133 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.4545 to $0.4610. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:46 UTC |
Kunin AudreyChief Product Officer
|
PurchaseCommon Stock | 25,000 | $0.46 | $11,500.00 |
DisclosureSEC source: 0001437749-21-027397 · rdgdoc.xml · nonDerivative · entry 1 Kunin Audrey · CIK 0001738781 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 25,000 F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:46 UTC |
Kunin JeffreyPresident, DERMAdoctor, LLC
|
PurchaseCommon Stock | 25,000 | $0.46 | $11,500.00 |
DisclosureSEC source: 0001437749-21-027396 · rdgdoc.xml · nonDerivative · entry 1 Kunin Jeffrey · CIK 0001738782 · President, DERMAdoctor, LLC 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 25,000 F2 · ownership.nature: By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control. Read SEC document |
| May 21, 2021 Filed May 25, 2021 20:47 UTC |
Freiman Paul E.Director
|
GrantRestricted Stock Unit · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-013297 · rdgdoc.xml · derivative · entry 1 Freiman Paul E. · CIK 0001410074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. Read SEC document |
| May 21, 2021 Filed May 25, 2021 20:46 UTC |
Zheng YenyouDirector
|
GrantRestricted Stock Unit · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-013293 · rdgdoc.xml · derivative · entry 1 Zheng Yenyou · CIK 0001330748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. Read SEC document |
| May 21, 2021 Filed May 25, 2021 20:47 UTC |
WU MIJIADirector
|
GrantRestricted Stock Unit · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-013296 · rdgdoc.xml · derivative · entry 1 WU MIJIA · CIK 0001664299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. Read SEC document |
| May 21, 2021 Filed May 25, 2021 20:46 UTC |
Sit SwanDirector
|
GrantRestricted Stock Unit · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-013295 · rdgdoc.xml · derivative · entry 1 Sit Swan · CIK 0001801128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. Read SEC document |
| May 21, 2021 Filed May 25, 2021 20:46 UTC |
Li XinzhouDirector · 10% owner
|
GrantRestricted Stock Unit · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-013294 · rdgdoc.xml · derivative · entry 1 Li Xinzhou · CIK 0001565534 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. Read SEC document |
| May 04, 2021 Filed May 7, 2021 22:00 UTC | Tax withholdingCommon Stock | 77,994 | $0.79 | $61,833.64 |
DisclosureSEC source: 0001437749-21-011378 · rdgdoc.xml · nonDerivative · entry 1 Jones Andrew D. · CIK 0001811872 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,006 F1 · security: Represents payment of tax liability due to vesting of 160,000 time-based restricted stock units (as previously reported on Mr. Jones' Form 3, as filed with the SEC on May 13, 2020). Read SEC document |
|
| August 20, 2020 Filed Aug 24, 2020 16:49 UTC |
Xu WangNEO - Sr Mgr and Controller
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001437749-20-018610 · rdgdoc.xml · derivative · entry 1 Xu Wang · CIK 0001807054 · NEO - Sr Mgr and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2030-08-20 F1 · derivative.exercise_date: The stock option grant will vest over four years, with 25% vesting on the first anniversary of the grant date and 6.25% vesting very three months thereafter. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 20:49 UTC | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001437749-20-018608 · rdgdoc.xml · derivative · entry 1 Jones Andrew D. · CIK 0001811872 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-08-20 F1 · derivative.exercise_date: The stock option grant will vest over four years, with 25% vesting on the first anniversary of the grant date and 6.25% vesting very three months thereafter. Read SEC document |
|
| August 20, 2020 Filed Aug 24, 2020 20:49 UTC |
Hall JustinCEO and GC
|
GrantStock Option (right to buy) · Derivative | 350,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001437749-20-018607 · rdgdoc.xml · derivative · entry 1 Hall Justin · CIK 0001663021 · CEO and GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common stock · 350,000 shares Expires 2030-08-20 F1 · derivative.exercise_date: The stock option grant will vest over four years, with 25% vesting on the first anniversary of the grant date and 6.25% vesting very three months thereafter. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:24 UTC |
WU MIJIADirector
|
OtherStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001437749-20-018340 · rdgdoc.xml · derivative · entry 3 WU MIJIA · CIK 0001664299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 20,000 shares Expires 2029-05-30 Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:24 UTC |
WU MIJIADirector
|
SaleCommon stock | 20,000 | $1.35 | $27,000.00 |
DisclosureSEC source: 0001437749-20-018340 · rdgdoc.xml · nonDerivative · entry 2 WU MIJIA · CIK 0001664299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.